NorthWest Biotherapeutics Inc (NWBO)

[Maverick0408]

Can someone post how many ndGBM cases are reported in UK and EU annually? And what percentage of that can NWBO conservatively address? Assuming treatment cost of $200k, we can build a conservative business model of their top line annual revenue, even if FDA doesn't play ball. IMO, this in itself likely deserves a higher market cap then where we are currently (even at full dilution)!